A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease

Molecular and Cellular Neuroscience

Volumn 36, Issue 3, 2007, Pages 313-331

  Xu, Pu Ting ^a   Li, Yi Ju ^a   Qin, Xue Jun ^a   Kroner, Charles ^a   Green Odlum, Anya ^a   Xu, Hong ^a   Wang, Tian Yuan ^a   Schmechel, Donald E ^a   Hulette, Christine M ^a   Ervin, John ^a   Hauser, Mike ^a   Haines, Jonathan ^b   Pericak Vance, Margaret A ^a   Gilbert, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Apolipoprotein E; Apoptosis; Serial analysis of gene expression (SAGE); Signal pathways

Indexed keywords

APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CALCIUM; NEUROTRANSMITTER RECEPTOR;

ALLELE; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CELL AGING; CELL CYCLE ARREST; CELL GROWTH; CELL PROTECTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENERGY METABOLISM; GENE EXPRESSION; GENE POOL; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NERVE CELL; NERVE CELL PLASTICITY; NERVE FIBER GROWTH; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RISK; SIGNAL TRANSDUCTION; SYNAPSE VESICLE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LIBRARY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; UP-REGULATION;

EID: 35448984980     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.06.009     Document Type: Article

References (53)

1. Alberts M.J., Graffagnino C., McClenny C., Delong D., Strittmatter W., Saunders A.M., and Roses A.D. ApoE genotype and survival from intracerebral haemorrhage. Lancet 346 (1995) 575
2. Anisimov S.V., Tarasov K.V., Stern M.D., Lakatta E.G., and Boheler K.R. A quantitative and validated SAGE transcriptome reference for adult mouse heart. Genomics 80 (2002) 213-222
3. Augustine G.J. How does calcium trigger neurotransmitter release?. Curr. Opin. Neurobiol. 11 (2001) 320-326
4. Auld D.S., Kornecook T.J., Bastianetto S., and Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog. Neurobiol. 68 (2002) 209-245
5. Beckmann L., Fischer C., Deck K.G., Nolte I.M., te M.G., and Chang-Claude J. Exploring haplotype sharing methods in general and isolated populations to detect gene(s) of a complex genetic trait. Genet. Epidemiol. 21 Suppl 1 (2001) S554-S559
6. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57 (1995) 289-300
7. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., and Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2173-2178
8. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl) 82 (1991) 239-259
9. Choi D.W. Alzheimer's disease and dementia. Med. Sect. Proc. (1988) 129-155
10. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., and Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70 (2002) 462-473
11. Coleman P.D., and Yao P.J. Synaptic slaughter in Alzheimer's disease. Neurobiol. Aging 24 (2003) 1023-1027
12. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
13. Corder E.H., Saunders A.M., Risch N.J., Strittmatter W.J., Schmechel D.E., Gaskell Jr. P.C., Rimmler J.B., Locke P.A., Conneally P.M., Schmader K.E., Small G.W., Roses A.D., Haines J.L., and Pericak-Vance M.A. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7 (1994) 180-184
14. Davis S., and Weeks D.E. Comparison of nonparametric statistics for detection of linkage analysis in nuclear families: single marker evaluation. Am. J. Hum. Genet. 61 (1997) 1431-1444
15. DeKosky S.T., and Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 27 (1990) 457-464
16. Eikelboom J.W., Anand S.S., Malmberg K., Weitz J.I., Ginsberg J.S., and Yusuf S. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without St elevation: a meta-analysis. Lancet 355 (2000) 1936-1942
17. Elliott N.A., and Volkert M.R. Stress induction and mitochondrial localization of Oxr1 proteins in yeast and humans. Mol. Cell. Biol. 24 (2004) 3180-3187
18. Evans S.J., Datson N.A., Kabbaj M., Thompson R.C., Vreugdenhil E., de Kloet E.R., Watson S.J., and Akil H. Evaluation of Affymetrix Gene Chip sensitivity in rat hippocampal tissue using SAGE analysis. Serial Analysis of Gene Expression. Eur. J. Neurosci. 16 (2002) 409-413
19. Galderisi U., Melone M.A., Jori F.P., Piegari E., Di Bernardo G., Cipollaro M., Cascino A., Peluso G., Claudio P.P., and Giordano A. pRb2/p130 gene overexpression induces astrocyte differentiation. Mol. Cell. Neurosci. 17 (2001) 415-425
20. George-Hyslop P.H., McLaurin J., and Fraser P.E. Neuropathological, biochemical and genetic alterations in AD. Drug News Perspect. 13 (2000) 281-288
21. Gunnersen J.M., Augustine C., Spirkoska V., Kim M., Brown M., and Tan S.S. Global analysis of gene expression patterns in developing mouse neocortex using serial analysis of gene expression. Mol. Cell. Neurosci. 19 (2002) 560-573
22. Harada J., and Sugimoto M. Inhibitors of interleukin-1 beta-converting enzyme-family proteases (caspases) prevent apoptosis without affecting decreased cellular ability to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in cerebellar granule neurons. Brain Res. 793 (1998) 231-243
23. Ho L., Guo Y., Spielman L., Petrescu O., Haroutunian V., Purohit D., Czernik A., Yemul S., Aisen P.S., Mohs R., and Pasinetti G.M. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique. Neurosci. Lett. 298 (2001) 191-194
24. 4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol. Psychiatry 5 (2000) 523-530
25. Hulette C.M., Welsh-Bohmer K.A., Crain B., Szymanski M.H., Sinclaire N.O., and Roses A.D. Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience. Arch. Pathol. Lab. Med. 121 (1997) 615-618
26. Iyer V., and Struhl K. Absolute mRNA levels and transcriptional initiation rates in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5208-5212
27. Kanai Y., Smith C.P., and Hediger M.A. The elusive transporters with a high affinity for glutamate. Trends Neurosci. 16 (1993) 365-370
28. 2+ sensor for neurotransmitter release. Trends Neurosci. 26 (2003) 413-422
29. Man M.Z., Wang X., and Wang Y. POWER_SAGE: comparing statistical tests for SAGE experiments. Bioinformatics 16 (2000) 953-959
30. Manczak M., Park B.S., Jung Y., and Reddy P.H. Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med. 5 (2004) 147-162
31. Margulies E.H., and Innis J.W. eSAGE: managing and analysing data generated with serial analysis of gene expression (SAGE). Bioinformatics 16 (2000) 650-651
32. Markesbery W.R. Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiol. Aging 4 Supplement 1 (1997) S13-S19
33. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., Van Belle G., and Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
34. Mufson E.J., Counts S.E., and Ginsberg S.D. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem. Res. 27 (2002) 1035-1048
35. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., and Pitas R.E. Differential effects of apolipoprotein E3 and E4 on neuronal growth in vitro. Science 264 (1994) 850-852
36. Ojaimi J., and Byrne E. Mitochondrial function and Alzheimer's disease. Biol. Signals Recept. 10 (2001) 254-262
37. Pasinetti G.M., and Ho L. From cDNA microarrays to high-throughput proteomics. Implications in the search for preventive initiatives to slow the clinical progression of Alzheimer's disease dementia. Restor. Neurol. Neurosci. 18 (2001) 137-142
38. Poirier J., Baccichet A., Dea D., and Gauthier S. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55 (1993) 81-90
39. Prolla T.A., and Mattson M.P. Molecular mechanisms of brain aging and neurodegenerative disorders: lessons from dietary restriction. TINS 24 (2001) S21-S31
40. Rebeck G.W., Reiter J.S., Strickland D.K., and Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11 (1993) 575-580
41. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38 (1995) 73-84
42. Saunders A.M., Schmader K.E., Breitner J.C., Benson M.D., Brown W.T., Goldfarb L., Goldgaber D., Manwaring M.G., Szymanski M.H., McCown N., Dole K.C., Schmechel D.E., Strittmatter W.J., Pericak-Vance M.A., and Roses A.D. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 342 (1993) 710-711
43. Scheff S.W., Price D.A., Schmitt F.A., and Mufson E.J. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 27 (2006) 1372-1384
44. Scott H.S., and Chrast R. Global transcript expression profiling by Serial Analysis of Gene Expression (SAGE). Genet. Eng. (NY) 23 (2001) 201-219
45. 2+ influx. Mol. Cell 15 (2004) 635-646
46. Stutzmann G.E. Calcium dysregulation, IP3 signaling, and Alzheimer's disease. Neuroscientist 11 (2005) 110-115
47. Su Z.Z., Leszczyniecka M., Kang D.C., Sarkar D., Chao W., Volsky D.J., and Fisher P.B. Insights into glutamate transport regulation in human astrocytes: cloning of the promoter for excitatory amino acid transporter 2 (EAAT2). Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 1955-1960
48. *3916) due to a rare mutation causing cryptic splice site activation. Hum. Immunol. 61 (2000) 467-473
49. Tardiff B.E., Newman M.F., Saunders A.M., Strittmatter W.J., Blumenthal J.A., White W.D., Croughwell N.D., Davis Jr. R.D., Roses A.D., and Reves J.G. Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center. Ann. Thorac. Surg. 64 (1997) 715-720
50. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., and Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30 (1991) 572-580
51. Velculescu V.E., Zhang L., Vogelstein B., and Kinzler K.W. Serial analysis of gene expression. Science 270 (1995) 484-487
52. Xu P.-T., Li Y.-J., Qin X.-J., Scherzer C.R., Xu H., Schmechel D.E., Hulette C.M., Ervin J., Gullans S.R., Haines J., Pericak-Vance M.A., and Gilbert J.R. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol. Dis. 21 (2006) 256-275
53. Yao P.J., Zhu M., Pyun E.I., Brooks A.I., Therianos S., Meyers V.E., and Coleman P.D. Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer's disease. Neurobiol. Dis. 12 (2003) 97-109